/ /

Fred Gebhart
6 tactics to measure astigmatism
Repeatability of corneal astigmatism measurement was compared using six different devices.
Real world performance drives formulary drug selection
Plans want more and better data on drug quality
How WFG ablations compare
In a comparison of two wavefront-guided excimer lasers, one platform provides better clinical results on some measures but cannot image certain eyes. The other system can image nearly all eyes, but has slightly less robust clinical results.
Real-world performance becomes key in drug selection
Drug evaluation and selection models are changing. Safety and efficacy have become the starting point for consideration by many payers. What they really want to see is evidence of superior performance in real world patient populations.
340B program works as intended
The 340B program is working just as Congress intended, helping hospitals stretch tight budgets to provide more and better patient care, said Ted Slafsky, MPP, president and chief executive officer of Safety Net Hospitals for Pharmaceutical Access.
All-femtosecond laser refractive procedure promising
Early FDA data with a femtosecond laser platform (VisuMax, Carl Zeiss Meditec) show positive results for corneal refractive surgery to treat uncomplicated myopia.
Femtosecond laser procedure for spherical myopia yields solid safety results
Initial FDA clinical trial outcomes of a femtosecond laser system (VisuMax, Carl Zeiss Meditec) to correct spherical myopia showed solid clinical and safety results.
LASIK rates highly among physician-patients
LASIK results are good. Studies using current LASIK platforms routinely show 20/20 in excess of 80% of eyes and a high degree of satisfaction in 95% of patients. With about one million eyes treated annually, LASIK results are so good the U.S. military has accepted the procedure for combat pilots. But what about physicians?


View Results